Visser Folkert W, Boonstra Arnold H, Titia Lely A, Boomsma Frans, Navis Gerjan
Department of Nephrology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Am J Hypertens. 2008 Mar;21(3):323-8. doi: 10.1038/ajh.2007.63. Epub 2008 Jan 24.
In hypertension, sodium sensitivity (SS) of blood pressure is associated with renal hemodynamic abnormalities related to increased activity of the renal renin-angiotensin aldosterone system (RAAS). The renal mechanisms of SS in normotensives are unknown. Therefore, we studied whether SS is related to renal hemodynamics and renal responsiveness to angiotensin II (AngII) in young healthy adults.
Blood pressure (mean arterial pressure (MAP)) and renal function were measured in 34 healthy men after 1-week low-sodium diet (LS; 50 mmol Na(+)/24 h), 1-week high-sodium diet (HS; 200 mmol Na(+)/24h), and 1-week HS-ACEi (enalapril 20 mg/day). The responses of effective renal plasma flow (ERPF; (131)I-Hippuran clearance) to graded infusion of AngII were assessed during each condition.
The sodium-induced change in MAP ranged from -7 to +14 mm Hg. SS (a sodium-induced increase in MAP >3 mm Hg) was present in 13 subjects. ERPF was lower in SS subjects during LS and during HS-ACEi. The AngII-induced decrease in ERPF was blunted in SS on LS (-25 +/- 6 vs. -29 +/- 7% in sodium-resistant (SR) subjects, P < 0.05) and on HS (-30 +/- 5 vs. -35 +/- 6%, P < 0.05). The blunting was corrected by angiotensin-converting enzyme inhibitors (ACEi) (-36 +/- 6 vs. -37 +/- 7%).
SS normotensive subjects have a blunted renal response to exogenous AngII. This is ameliorated by ACEi, supporting a role for inappropriately high intrarenal RAAS activity. As these findings cannot be attributed to subclinical renal hypertensive damage, high intrarenal RAAS activity and altered renal hemodynamics may be primary phenomena underlying SS.
在高血压患者中,血压的钠敏感性(SS)与肾血流动力学异常有关,而这种异常与肾素 - 血管紧张素 - 醛固酮系统(RAAS)活性增加有关。正常血压者中SS的肾脏机制尚不清楚。因此,我们研究了年轻健康成年人中SS是否与肾血流动力学及肾脏对血管紧张素II(AngII)的反应性有关。
对34名健康男性在1周低钠饮食(LS;50 mmol Na⁺/24 h)、1周高钠饮食(HS;200 mmol Na⁺/24 h)以及1周高钠 - 血管紧张素转换酶抑制剂(ACEi,依那普利20 mg/天)期间测量血压(平均动脉压(MAP))和肾功能。在每种情况下评估有效肾血浆流量(ERPF;(¹³¹)I - 马尿酸清除率)对分级输注AngII的反应。
钠诱导的MAP变化范围为 -7至 +14 mmHg。13名受试者存在SS(钠诱导的MAP升高>3 mmHg)。在LS期间和HS - ACEi期间,SS受试者的ERPF较低。在LS时(-25±6%对钠抵抗(SR)受试者的 -29±7%,P<0.05)和HS时(-30±5%对 -35±6%,P<0.05),SS受试者中AngII诱导的ERPF降低减弱。这种减弱通过血管紧张素转换酶抑制剂(ACEi)得到纠正(-36±6%对 -37±7%)。
血压正常的SS受试者对外源性AngII的肾脏反应减弱。ACEi可改善这种情况,支持肾内RAAS活性过高的作用。由于这些发现不能归因于亚临床肾性高血压损害,肾内RAAS活性过高和肾血流动力学改变可能是SS的主要潜在现象。